<?xml version="1.0" encoding="UTF-8"?>
<p>We have expanded the watch list generated by us in a previous study by including antibody escape mutations against three additional antibodies interacting with EBOV GP. These watch list mutations are those predicted to both disrupt GPâ€”antibody binding and yet allow GP to fold and form trimers.</p>
